Eagle Pharmaceuticals
EGRX
#10434
Rank
C$6.83 M
Marketcap
C$0.53
Share price
0.00%
Change (1 day)
-43.73%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: C$6.83 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of C$6.83 Million. This makes Eagle Pharmaceuticals the world's 10434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$6.83 M-14.45%
2025C$7.98 M-21.92%
2024C$10.22 M-88.65%
2023C$90.08 M-82.55%
2022C$0.51 B-38.4%
2021C$0.83 B8.31%
2020C$0.77 B-27.66%
2019C$1.06 B40.06%
2018C$0.76 B-23.8%
2017C$1.00 B-39.26%
2016C$1.65 B-14.21%
2015C$1.92 B661.76%
2014C$0.25 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
C$6.83 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$683.20 B 10,000,371.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$141.29 B 2,068,094.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
C$376.79 B 5,515,311.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
C$50.95 B 745,707.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
C$243.62 B 3,565,985.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.322 T 19,362,434.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$157.77 B 2,309,287.82%๐Ÿ‡บ๐Ÿ‡ธ USA